Retour
Prix NervGen Pharma Corp (NGENF)
Graphique du cours de l'action NGENF
NGENF Dividendes
NervGen Pharma Corp
$5.63
2.92%
$0.16
À la fermeture : Jan 16, 16:00:00 GMT-5
$5.63
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$5.47
Prix d'ouverture
$5.3
Plage de la journée
$5.3 - $5.81
Plage de 52 semaines
$1.5 - $6.3
Volume
27.4K
Volume moyen
143.6K
BPA (TTM)
-0.26
Rendement en dividend
--
Capitalisation boursière
$445.9M
Qu’est-ce que NGENF ?
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
